Currently, Lynparza is the first and only approved medicine targeting the breast cancer gene mutations in early-stage...

Readers write in from Siliguri, Gaya and Calcutta...

Study is likely to be conducted at six sites, including AIIMS Delhi and Patna...

It is a one-dose jab and the same as the first component recombinant human adenovirus serotype number 26...

The Central Drugs Standard Control Organisation approved molnupiravir for subsets of patients, but a clinical task force has not introduced it into treatment guidelines yet...

The companies have planned to market Molnupiravir capsules under their respective brands and make them available at all leading pharmacies...

The Central Drugs Standard Control Organisation approved the extension of Covaxin's shelf life up to 12 months from the date of manufacture...

Corbevax, an RBD protein sub-unit vaccine, has been developed with supported from the Department of Biotechnology...

Readers write in from Calcutta, Muzaffarpur, Ujjain, Berhampur and Baruipur...

World's first DNA-based jab when injected produces spike protein of SARS-CoV-2 virus to elicit immune response...